Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Patent
1995-05-31
1996-12-03
Ivy, C. Warren
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
560115, 560159, 560160, 562450, 562555, C07C 6976, C07C27100, C07C22700
Patent
active
055810110
ABSTRACT:
The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy;
REFERENCES:
patent: 3687956 (1972-08-01), Zivkovic
patent: 3806526 (1974-04-01), Carr et al.
patent: 3829433 (1974-08-01), Carr et al.
patent: 3839431 (1974-10-01), Sheehan et al.
patent: 3862173 (1975-01-01), Carr et al.
patent: 3878217 (1975-04-01), Carr et al.
patent: 3898271 (1975-08-01), Sheehan et al.
patent: 3922276 (1975-11-01), Duncan et al.
patent: 3931197 (1976-01-01), Carr et al.
patent: 3941795 (1976-03-01), Carr et al.
patent: 3946022 (1976-03-01), Carr et al.
patent: 3956296 (1976-05-01), Duncan et al.
patent: 3965257 (1976-06-01), Carr et al.
patent: 4028404 (1977-07-01), Bays et al.
patent: 4254129 (1981-03-01), Carr et al.
patent: 4254130 (1981-03-01), Carr et al.
patent: 4285957 (1981-08-01), Carr et al.
patent: 4285958 (1981-08-01), Carr et al.
patent: 4407823 (1983-10-01), Kirsch et al.
patent: 4550116 (1985-10-01), Soto et al.
patent: 4742175 (1988-05-01), Fawcett et al.
patent: 5375693 (1994-12-01), Woosley et al.
K. Y. Chan, et al., "Direct enantiomeric separation of terfenadine and its major acid metabolite by high-performance liquid chromatography, and the lack of stereoselective terfenadine enantiomer biotransformation in man," Journal of Chromatography, 271:291-97 (1991).
F. J. McCarty, et al., "Central Depressants. Phosphoramidates Derived from .alpha.,.alpha.-Disubstituted 4-Piperidinemethanols," Department of Organic Research, Scientific Laboratories, (1961).
Chemical Abstract, vol. 94, 1981, p. 644, 94:156758e.
Chemical Abstract, vol. 110, 1989, p. 762, 110:173097e.
Woosley, R. L., et al. "Mechanism of the Cardiotoxic Actions of Terfenadine," JAMA 269 (12):1532-36 (Mar. 1993).
Honig, P. K., et al. "Terfenadine-ketoconazole Interaction. Pharmacokinetic and Electrocardiographic Consequences," JAMA, 269 (12):1513-18 (Mar. 1993).
Kuhlman, J. J., Jr., "Measurement of Azacyclonol in Urine and Serum of Humans Following Terfenadine (Seldane) Administration Using Gas Chromatography-mass Spectrometry," J Chromatogr 578 (2):207-13 (Jul. 1992).
Honig, P. K., et al., "Changes in the Pharmacokinetics and Electrocardiographic Pharmacodynamics of Terfenadine with Concomitant Administration of Erythromycin," Clin Pharmacol Ther 52(3):231-8 (Sep. 1992).
Chen, T. M., et al., "Determination of the Metabolites of Terfenadine in Human Urine by Thermospray Liquid Chromatography-Mass Spectrometry," J. Pharm. Biomed. Anal. 9(10-12):929-33, (1991).
Sepracor Inc. Accounces Second Quarter 1993 Financial Results, Business Wire, Inc. (Jul. 1993).
Marion Merrell Dow Restructures, The Financial Times Limited (Jul. 1993).
Marion Merrell Invests in Sepracor, Chemical Week Associates (Jun. 1993).
Sepracor, Inc. Accounces Agreement with Marion, Business Wire, Inc. (Jun. 1993).
Sepracor Licenses Rights to Marion Merrell, Reuters, Limited (Jun. 1993).
Drug Makers Contend with Inevitable Change, Chemical Week Associates (Mar. 1993).
Drug Pipelines Point to a Mixed Future, Chemical Week Associates (Mar. 1993).
Not Associated with Cardiac Effects of Leading Prescription, Non-sedative Antihistamines; JAMA Study First to Demonstrate Potential Theraupeutic Benefits of Active Metabolite of Terfenadine, Business Wire, Inc. (Mar. 1993).
R. T. Morrison, et al., Organic Chemistry, pp. 661-662 (3rd ed., 1974).
Maurer, H., et al., "Identification and Differentiation of Alkylamine Antihistamines and Their Metabolites I Urine by Computerized Gas Chromatography-Mass Spectrometry," J. Chromatogr 430(1):31--31 (Aug. 1988).
Simons, F. E., et al., "Lack of Subsensitivity to Terfenadine During Long-Term Terfenadine Treatment," J. Allergy Clin Immunol 82(6):1068-75 (Dec. 1988).
Shall, L., et al., "Assessment of the Duration of Action of Terfenadine on Histamine Induced Weals," Br. J. Dermatol 119(4):525-31 (Oct. 1988).
Akagi, M., "Antiallergic Effects of Terfenadine on Immediate Type Hypersensitivity Reactions," Immunopharmacol Immunotoxicol 9(2-3):257-79 (1987).
Snyder, S. H., et al., "Receptor Effects of Cetirizine," Ann Allergy 59(6-2):4-8 (Dec. 1987).
Simons, F. E., "The Pharmacokinetics and Pharmacodynamics of Terfenadine in Children," J. Allergy Clin Immunol. (6):884-90 (1987).
Carter, C. A., et al., "Terfenadine, A Nonsedating Antihistamine," Drug Intell Clin Pharm 19(11):812-7 (Nov. 1985).
Paton, D. M., et al., "Clinical Pharmacokinetics of H1-Receptor Antagonists (He Antihistamines) Clin Pharmacokinet," 10(6):477-97 (Nov.-Dec. 1985).
Woodward, J. K., "Terfenadine, the First Non-Sedating Antihistamine," Arzneimittelforschung 32(9a):1154-6 (1982).
Cook, C. E., et al., "Radioimmunoassay for Terfenadine in Human Plasma," J. Pharm Sci 69(12):1419-23 (Dec. 1980).
Snowman, A. M., et al., "Cetirizine: Actions on Neurotransmitter Receptors," J. Allergy Clin. Immunol. 86(6-2)1025-8 (Dec. 1990).
Berman, B. D., "Perennial Allergic Rhinitis: Clinical Efficacy of a New Antihistamine," J. Allergy Clin. Immunol. 86 (68-2)1004-(Dec. 1990).
Monahan, B. P., et al., "Torsades de Pointes Occurring in Association with Terfenadine Use," JAMA, 264(21) 2788-90 (Dec. 1990).
Simons, K. J., et al., "Pharmacokinetics and Pharmacodynamics of Terfenadine and Chlorpheniramine In the Elderly," J. Allergy Clin. Ummunol. 85(3):540-7 (Mar. 1990).
Sweeney, G. D., et al., "Anti-Allergy and Anti-Asthma Drugs. Disposition in Infancy and Childhood," Clin. Pharmacokinet, 17 Suppl (1):156-68 (1989).
Coniglio, A. A., "Effect of Acute and Chronic Terfenadine on Free and total Serum Phenytoin Concentrations in Epileptic Patients," Epilepsia 30(5):611-6 (Sep.-Oct. 1989).
Mann, K. V., et al., "Nonsedating Histamine H1-Receptor Antagonists," Clin. Pharm. 8(5):331-44 (May 1898).
Barenhotz, H. A., "Loratadine: A Non Sedating Antihistamine with Once-Daily Dosing," DICP 23(6):44550 (Jun. 1989).
Brion, N., et al., "Lack of Effect of Terfenadine on Theophylline Pharmacokinetics and Metabolism in Normal Subjects," Br J. Clin. Pharmacol., 27(3):391-5 (Mar. 1989).
Kaliner, M. A., "Non-sedating Antihistamines," Allergy Proc. 9(6):649-63 (Nov.-Dec. 1988).
Zamani, K., et al., "Enantiomeric Analysis of Terfenadine in Rat Plasma by HPLC," Chirality, 3(6):467-70 (199).
Eller, M. G., et al., "Absence of Food Effects on the Pharmacokinetics of Terfenadine," Biopharm. Drug Dispos. 13(3):171-7 (Apr. 1992).
Chan, K. Y., "Direct Enantiomeric Separation of Terfenadine and its Major Acid Metabolite by High-Performance Liquid Chromatography, and the Lack of Stereoselective Terfenadine Enantiomer Biotransformation in Man," J. Chromatogr. 571(1-2) 291-7 (1991).
Eller, M. G., et al., "Pharmacokinetics of Terfenadine in Healthy Elderly Subjects," J. Clin. Pharmacol. 32(3):267-71 (Mar. 1992).
Coutant, J. E., et al. "Determination of Terfenadine and Terfenadine Acid Metabolite in Plasma using Solid-Phase Extraction and High-Performance Liquid Chromatography with Fluorescence Detection," J. Chromatogr. 570(1):139-48 (1991).
Luo, H., et al. "N(+)-glucuronidation of Aliphatic Tertiary Mines, A General Phenomenon in the Metabolism of H1-antihistamines in Humans," Xenobiotca., 21(10):1281-8 (Oct. 1991).
Estelle, F., et al., "Pharmacokinetic Optimisation of Histamine H1-Receptor Antagonist Therapy," Clin. Pharmacokinet., 21(5):372-93 (Nov. 1991).
Shall, L. et al., "Dose-Response Relationship Between Objective Measures of Histamine-Induced Weals and Dose of Terfenadine," Acta. Derm. Venereol. 71(3):199-204 (1991).
Campoli-Richards, D. M., et al., "Cetirizine. A Review of its Pharmacological Properties and Clinical Potential in Allergic Rhinitis, Pollen-Induced Asthma, and Chronic Urticaria," Drugs 40(5)762-81 (Nov. 1990).
Albany Molecular Research, Inc.
Covington Raymond
Ivy C. Warren
LandOfFree
Aromatic ketones and processes for their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aromatic ketones and processes for their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aromatic ketones and processes for their preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-786853